These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10415445)

  • 1. [Basic examination of hepatitis C virus (HCV) core protein quantitative method and the clinical significance in during the follow-up of the patients after interferon treatment].
    Suyama Y; Mishima S; Iwata Y; Ishikura H; Shibata H; Masuda J
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 1999; 10(1):13-9. PubMed ID: 10415445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
    Kawai S; Yokosuka O; Imazeki F; Saisho H; Mizuno C
    J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance and problems in HCV measurement--comparison of CLEIA method with PCR method].
    Ohta H; Takemura M; Furuta N; Akiyama M; Katagiri Y; Ohashi H; Takahashi K; Saito K; Seishima M
    Rinsho Byori; 2004 Oct; 52(10):813-8. PubMed ID: 15624496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical benefit of HCV core antigen assay in patients receiving interferon and ribavirin combination therapy].
    Higashimoto M; Takahashi M; Jokyu R; Saito H
    Rinsho Byori; 2006 Feb; 54(2):111-5. PubMed ID: 16548229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the efficacy of antiviral therapy for hepatitis C virus infection by an ultrasensitive RT-PCR assay.
    Kinai E; Hanabusa H; Kato S
    J Med Virol; 2007 Aug; 79(8):1113-9. PubMed ID: 17596840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems.
    Cagnon L; Wagaman P; Bartenschlager R; Pietschmann T; Gao T; Kneteman NM; Tyrrell DL; Bahl C; Niven P; Lee S; Simmen KA
    J Virol Methods; 2004 Jun; 118(1):23-31. PubMed ID: 15158065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.
    Alzahrani AJ
    J Med Virol; 2008 Apr; 80(4):603-6. PubMed ID: 18297713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
    Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
    J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sequential monitoring of various HCV-related markers in chronic hepatitis C with interferon treatment].
    Nagayama R; Shoji S; Miyake K
    Nihon Rinsho; 1994 Jul; 52(7):1789-93. PubMed ID: 7521419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.
    Bouvier-Alias M; Patel K; Dahari H; Beaucourt S; Larderie P; Blatt L; Hezode C; Picchio G; Dhumeaux D; Neumann AU; McHutchison JG; Pawlotsky JM
    Hepatology; 2002 Jul; 36(1):211-8. PubMed ID: 12085367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of RT-PCR method for detection of HCV-RNA--with special reference to Amplicor HCV].
    Furuwatari C; Suzuki K; Matsumoto A; Kobayashi M; Kiyosawa K; Hidaka E; Ueno I; Ogiso Y; Furihata K; Katsuyama T
    Rinsho Byori; 1997 Aug; 45(8):790-4. PubMed ID: 9283232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
    Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
    J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.
    Tanaka E; Ohue C; Aoyagi K; Yamaguchi K; Yagi S; Kiyosawa K; Alter HJ
    Hepatology; 2000 Aug; 32(2):388-93. PubMed ID: 10915747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy.
    Zanetti AR; Romanò L; Brunetto M; Colombo M; Bellati G; Tackney C
    J Med Virol; 2003 May; 70(1):27-30. PubMed ID: 12629640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of core antigen detection in management of hepatitis C: a critical review.
    Seme K; Poljak M; Babic DZ; Mocilnik T; Vince A
    J Clin Virol; 2005 Feb; 32(2):92-101. PubMed ID: 15653411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fundamental evaluation of HCV core antigen method comparison with Cobas Amplicor HCV monitor v2.0 (high range method)].
    Okazaki K; Nishiyama Y; Saitou T; Shibata N; Yamamoto C; Oosaga J; Tanaka M; Ichiyama S
    Rinsho Byori; 2008 Feb; 56(2):95-100. PubMed ID: 18402050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
    Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TaqMan amplification system with an internal positive control for HCV RNA quantitation.
    Castelain S; Descamps V; Thibault V; François C; Bonte D; Morel V; Izopet J; Capron D; Zawadzki P; Duverlie G
    J Clin Virol; 2004 Nov; 31(3):227-34. PubMed ID: 15465417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.